GlassScriptPhysician profile
Lara Oakes
NPI 1518109040
$386.40
in general payments reported to CMS, 2019-2025
8 companies · $115 in 2025
The $115 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $60.41 · 2022: $62.06 · 2023: $66.48 · 2024: $82.31 · 2025: $115.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $264.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $263.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $121.47 | 2021-2025 | Mounjaro, Zepbound |
| Abbvie INC. | $95.84 | 2022-2024 | |
| Novo Nordisk INC | $61.11 | 2023-2025 | Ozempic, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $38.05 | 2022-2024 | Airsupra |
| Ge Healthcare | $24.96 | 2025 | |
| Exact Sciences Corporation | $15.25 | 2025 | Cologuard Collection Kit |
| Xeris Pharmaceuticals, INC. | $15.19 | 2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $14.53 | 2025 | Caplyta |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lara Oakes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.